222 related articles for article (PubMed ID: 6420600)
21. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
22. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
Xu H; Rizzo LV; Silver PB; Caspi RR
Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells.
Brown PH; Thorbecke GJ
J Immunol; 1985 Nov; 135(5):3572-80. PubMed ID: 3900211
[TBL] [Abstract][Full Text] [Related]
24. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
Katz JD; Lebow LT; Bonavida B
J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
[TBL] [Abstract][Full Text] [Related]
25. Ia dependent lymphokine production in the syngeneic mixed lymphocyte response.
Lattime EC; Macphail S; von Wussow P; Stutman O
Behring Inst Mitt; 1983 May; (72):47-58. PubMed ID: 6085748
[TBL] [Abstract][Full Text] [Related]
26. Suppression of spontaneous reticulum cell sarcoma development and of syngeneic stimulator cell by anti-mu treatment of SJL/J mice.
Katz IR; Asofsky R; Thorbecke GJ
J Immunol; 1980 Sep; 125(3):1355-9. PubMed ID: 6774017
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.
Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K
J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456
[TBL] [Abstract][Full Text] [Related]
28. Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone.
Koyasu S; Nakauchi H; Kitamura K; Yonehara S; Okumura K; Tada T; Yahara I
J Immunol; 1985 May; 134(5):3130-6. PubMed ID: 2580015
[TBL] [Abstract][Full Text] [Related]
29. Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
DeKruyff RH; Brown PH; Thorbecke GJ; Ponzio NM
J Immunol; 1985 Nov; 135(5):3581-6. PubMed ID: 2413126
[TBL] [Abstract][Full Text] [Related]
30. Developmental regulation of IL-4, IL-2, and IFN-gamma production by murine peripheral T lymphocytes.
Adkins B; Ghanei A; Hamilton K
J Immunol; 1993 Dec; 151(12):6617-26. PubMed ID: 7903095
[TBL] [Abstract][Full Text] [Related]
31. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
Ihle JN; Lee JC; Rebar L
J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
[TBL] [Abstract][Full Text] [Related]
32. Difference in the functional maturation of T cells against Listeria monocytogenes in lymph nodes and spleen.
Serushago BA; Mitsuyama M; Handa T; Muramori K; Koga T; Nomoto K
Immunology; 1992 Feb; 75(2):238-44. PubMed ID: 1551686
[TBL] [Abstract][Full Text] [Related]
33. The cellular basis for immune interferon production in autoimmune MRL-Ipr/Ipr mice.
Santoro TJ; Benjamin WR; Oppenheim JJ; Steinberg AD
J Immunol; 1983 Jul; 131(1):265-8. PubMed ID: 6408174
[TBL] [Abstract][Full Text] [Related]
34. T cells in inductive and effector compartments of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function.
James SP; Kwan WC; Sneller MC
J Immunol; 1990 Feb; 144(4):1251-6. PubMed ID: 1689347
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
[TBL] [Abstract][Full Text] [Related]
36. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
38. In vitro production of interleukin-4 and interferon-gamma by lymph node cells from BALB/c mice infested with nymphal Ixodes ricinus ticks.
Ganapamo F; Rutti B; Brossard M
Immunology; 1995 May; 85(1):120-4. PubMed ID: 7635513
[TBL] [Abstract][Full Text] [Related]
39. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
Orosz CG; Zinn NE; Olsen RG; Mathes LE
J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
[TBL] [Abstract][Full Text] [Related]
40. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.
Thomson JA; Troutt AB; Kelso A
Immunology; 1993 Feb; 78(2):185-92. PubMed ID: 8473011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
